A 6-Month Study Comparing Efficacy, Safety, and Tolerability of the Preservative-free Fixed Combination of Tafluprost 0.0015% and Timolol 0.5% versus Each of Its Individual Preservative-Free Components

INTRODUCTION: The efficacy, safety and tolerability of the preservative-free (PF) fixed combination (FC) of tafluprost 0.0015% and timolol 0.5% (once daily) were compared to those of the individual components (PF tafluprost 0.0015% once daily and PF timolol 0.5% twice daily) in patients with open-an...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfeiffer, Norbert, Traverso, Carlo E., Lorenz, Katrin, Saarela, Ville, Liinamaa, Johanna, Uusitalo, Hannu, Astakhov, Yury, Boiko, Ernest, Ropo, Auli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271134/
https://www.ncbi.nlm.nih.gov/pubmed/25447269
http://dx.doi.org/10.1007/s12325-014-0163-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271134/
https://www.ncbi.nlm.nih.gov/pubmed/25447269
http://dx.doi.org/10.1007/s12325-014-0163-3

Ejemplares similares